Results of treatment of severe carpal-tunnel syndrome without internal neurolysis of the median nerve

R. H. Gelberman, G. B. Pfeffer, R. T. Galbraith, Robert M Szabo, B. Rydevik, M. Dimick

Research output: Contribution to journalArticle

133 Scopus citations

Abstract

Thirty-three hands (twenty-nine patients) had a release of the carpal tunnel without internal neurolysis for severe carpal-tunnel syndrome. All of the hands had increased values for two-point discrimination or thenar atrophy, or both. Twenty-three (89 per cent) of the twenty-six hands that had increased values for two-point discrimination and twenty-six (87 per cent) of the thirty hands that had an elevated result on Semmes-Weinstein testing had normal values at follow-up. Nine (90 per cent) of the ten hands that had weakness of the thenar muscles (grade-3-strength or less) regained grade-4 or 5 strength. Thirteen (65 per cent) of the twenty hands that had thenar atrophy regained normal muscle bulk. Eighteen (62 per cent) of the twenty-nine patients had complete resolution of symptoms and signs of compression of the median nerve. No significant difference was found between the results in this series of patients and those in a previously reported similar group of patient who were treated by release of the carpal tunnel combined with internal neurolysis of the median nerve.

Original languageEnglish (US)
Pages (from-to)896-903
Number of pages8
JournalJournal of Bone and Joint Surgery - Series A
Volume69
Issue number6
StatePublished - 1987

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Fingerprint Dive into the research topics of 'Results of treatment of severe carpal-tunnel syndrome without internal neurolysis of the median nerve'. Together they form a unique fingerprint.

  • Cite this

    Gelberman, R. H., Pfeffer, G. B., Galbraith, R. T., Szabo, R. M., Rydevik, B., & Dimick, M. (1987). Results of treatment of severe carpal-tunnel syndrome without internal neurolysis of the median nerve. Journal of Bone and Joint Surgery - Series A, 69(6), 896-903.